In early September, ONC issued a request for information (RFI) for public stakeholders to share their views on the components of the EHR Reporting Program and to provide feedback that will inform the development of EHR Reporting Program criteria and processes. This program is part of the 21st Century Cures Act and will be part of a new set of programs known as the Conditions of Certification.
Software is increasingly used in healthcare to promote wellness, treat and diagnose disease, aid clinical decision making, and manage patient care. The ability to download these software programs onto ubiquitously connected mobile platforms allows them to be used in the hospital and in the home, by clinicians and patients. These software-based technologies, including mobile medical apps, are what FDA and other regulators call “Software as a Medical Device” (SaMD).
This webinar will present the white paper derived from the AMIA 2017 Policy Invitational. The paper details a new set of policy principles and framework meant to address cross-cutting issues identified by API17 participants and to encourage a more unified care, research, wellness, and community ecosystem. Entitled, “Redefining Our Picture of Health: Towards a Person-Centered Integrated Care, Research, Wellness, and Community Ecosystem” it also includes a set of draft recommendations that highlight ways in which the federal government can facilitate this ecosystem.
In mid-October 2017, AMIA supported the launch of an American Medical Association-led Integrated Health Model Initiative, or IHMI. This multi-stakeholder effort features (1) a digital platform for collaborative communities around costly and burdensome areas of care; (2) a general purpose, machine-readable information model, known as the Integrated Health Model; and (3) a clinical validation process to review submissions and incorporate feedback from the use of IHM.
Passage of the 21st Century Cures Act was a watershed moment for the 114th Congress. After more than two years of hearings, debates and negotiations, House and Senate leadership produced a sprawling package that will touch every corner of basic, clinical and translational research, drug and device development, care delivery and public health.
The Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012 calls for the HHS Secretary to "post a report -- within 18 months (or by January 2014) - that contains a proposed strategy and recommendations on a risk-based regulatory framework pertaining to health IT, including mobile applications, that promotes innovation, protects patient safety, and avoids regulatory duplication."
The "Common Rule" is a set of federal regulations that has the purpose of protecting research subjects. This webinar is intended to give an overview of Common Rule, describe when research studies are subject to it, and describe in particular how it can impact some types of studies that AMIA members might conduct.
You should register for this webinar if you are interested in learning about the federal regulations for protecting research subjects and how the regulations might apply to your work.
During this webinar you will learn about:
By engaging consumers in their healthcare, they are more likely to take better care of themselves, which lowers costs, improves health outcomes and cultivates consumer loyalty. Consumer engagement is critical to healthcare reform and strengthens providers’ ability to meet Meaningful Use incentive requirements as well as supporting other patient-centered care programs.
This session will provide an introduction to the recent Office of the National Coordinator for Health Information Technology Workgroup Report on the Unintended Consequences of Health Information Exchange (HIE UCs). The Webinar will begin with a brief overview of health information exchange, its goals and the ways it can be achieved. The Webinar then will present a 7-part framework for understanding the potential unintended consequences that may result from the implementation of health information exchange.